| Literature DB >> 35035882 |
Supawan Surukrattanaskul1, Pukkapol Suvannachart2, Sunee Chansangpetch2, Anita Manassakorn2, Visanee Tantisevi2, Prin Rojanapongpun2.
Abstract
Purpose: To evaluate the clinical characteristics and treatment outcomes of patients with childhood glaucoma.Entities:
Keywords: Childhood Glaucoma Research Network classification; childhood glaucoma; congenital glaucoma; paediatric eye disease; paediatric glaucoma; retrospective cohort
Mesh:
Year: 2021 PMID: 35035882 PMCID: PMC8738969 DOI: 10.12688/f1000research.51256.2
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Clinical and demographic characteristics of the study participants.
| Characteristics | Total | PCG | JOAG | SCG-C | SCG-S | SCG-O | SCG-A | GS |
|---|---|---|---|---|---|---|---|---|
| Number of eyes (patients) | 691 (423) | 145 (88) | 15 (8) | 54 (33) | 45 (32) | 156 (97) | 117 (80) | 159 (85) |
| Gender (patients, %)
|
|
|
|
|
|
|
|
|
| Age at presentation (years) | 1.6 (0.3 to 6.8) | 0.4 (0.2 to 4.4) | 8.4 (5.3 to 12.4) | 5.6 (1.8 to 7.6) | 2.1 (0.4 to 6.3) | 0.3 (0 to 3.0) | 6.8 (2.8 to 10.4) | 2.7 (0.6 to 7.7) |
| Family history (patients, %) *
|
|
|
|
|
|
|
|
|
| Laterality (patients, %)
|
|
|
|
|
|
|
|
|
| Refraction (eyes, SE) † | -1.25 (-3.19 to 0) | 2.12 | 0 | -2.25 (-6.63 to 5.50) | 0.50 (0 to 1.25) | -2.88 (-3.25 to 3.00) | -1.25 (-2.00 to -0.25) | 0.63 (-0.50 to 1.50) |
| Corneal diameter (eyes, mm) | 11.5 (10 to 13) | 12.5 (12 to 13) | 10.5 (10 to 12) | 10 (10 to 12) | 11.5 (9 to 12.3) | 11 (9 to 12.3) | 11 (10 to 12) | 11 (10 to 12) |
| Cup to disc ratio (eyes) ‡ | 0.6 (0.3 to 0.8) | 0.8 (0.6 to 0.9) | 0.9 (0.9 to 1.0) | 0.4 (0.3 to 0.7) | 0.5 (0.3 to 0.8) | 0.3 (0.2 to 0.4) | 0.4 (0.3 to 0.7) | 0.6 (0.5 to 0.8) |
Data shown in median (interquartile range).
Refraction, corneal diameter, and cup to disc ratio were the measurements taken at first visit.
* Data available in 234, 35, 5, 13, 15, 56, 50, and 60 patients for total, PCG, JOAG, SCG-C, SCG-S, SCG-O, SCG-A, and GS, respectively.
† Data available in 93, 1, 2, 16, 5, 5, 19, and 45 eyes for total, PCG, JOAG, SCG-C, SCG-S, SCG-O, SCG-A, and GS, respectively.
‡ Data available in 426, 71, 14, 39, 34, 41, 71, and 156 eyes for total, PCG, JOAG, SCG-C, SCG-S, SCG-O, SCG-A, and GS, respectively.
IOP, intraocular pressure; SE, spherical equivalence; PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions; GS, glaucoma suspect.
Mode of detection patterns in eyes with a glaucoma diagnosis.
| Mode of detection patterns | Total | PCG | JOAG | SCG-C | SCG-S | SCG-O | SCG-A |
|---|---|---|---|---|---|---|---|
| Presented with glaucoma-related
|
|
|
|
|
|
|
|
| From clinical surveillance or screening
| 126 | - | 6 | 32 | 17 | 9 | 62 |
| Unknown / missing data | 73 | 27 | 6 | 15 | 6 | 6 | 13 |
Data shown in number of eyes (%).
* Including eyes from clinical surveillance in known systemic or ocular diseases, clinical surveillance due to family history of glaucoma and other forms of child health screening.
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions.
Figure 1. Subtypes of childhood glaucoma.
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions; GS, glaucoma suspect.
Figure 2. Causes of secondary glaucoma subtypes that are associated with non-acquired systemic disease, non-acquired ocular anomalies, and acquired conditions.
Figure 3. Type of glaucoma interventions in eyes with a glaucoma diagnosis.
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions.
Surgical procedures for each glaucoma subtype.
| PCG | JOAG | SCG-C | SCG-S | SCG-O | SCG-A | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgery | n | % | n | % | n | % | n | % | n | % | n | % |
| first trabeculectomy | 25 | 19.08 | 2 | 33.33 | 8 | 34.78 | 8 | 27.59 | 27 | 28.72 | 16 | 45.71 |
| trabeculectomy revision | 17 | 12.98 | 4 | 17.39 | 4 | 13.79 | 12 | 12.77 | 8 | 22.86 | ||
| glaucoma drainage device | 13 | 9.92 | 4 | 66.67 | 2 | 8.70 | 2 | 6.90 | 4 | 4.26 | 4 | 11.43 |
| trabeculotomy | 17 | 12.98 | 2 | 6.90 | 7 | 7.45 | ||||||
| goniotomy | 20 | 15.27 | 4 | 13.79 | 2 | 2.13 | ||||||
| trabeculotomy + trabeculectomy | 21 | 16.03 | 2 | 6.90 | 10 | 10.64 | ||||||
| GDD + trabeculectomy | 1 | 0.76 | 1 | 4.35 | ||||||||
| ECP | 1 | 0.76 | 3 | 13.04 | 3 | 10.34 | 4 | 4.26 | 1 | 2.86 | ||
| DTSCP | 16 | 12.21 | 5 | 21.74 | 4 | 13.79 | 28 | 29.79 | 6 | 17.14 | ||
| Total | 131 | 100.00 | 6 | 100.00 | 23 | 100.00 | 29 | 100.00 | 94 | 100.00 | 35 | 100.00 |
Data shown in frequency and percentage of eyes
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions; GDD glaucoma drainage device; ECP endocyclophotocoagulation; DTSCP diode transscleral cyclophotocoagulation
Visual acuity and intraocular pressure in eyes with a glaucoma diagnosis.
| Follow up
| Initial visual acuity N (%) | Last visual acuity N (%) | P value
| Initial
| Last
| P
| |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Favorable | Moderately
| Unfavorable | Favorable | Moderately
| Unfavorable | ||||||
| All
| 60 (27 to 122) | 103 (39.0%) | 58 (22.0%) | 103 (39.0%) | 140 (34.7%) | 64 (15.8%) | 200 (49.5%) | 0.03 | 28.5 (11.2) | 19.1 (10.8) | <0.001 |
| PCG | 83 (36 to 134) | 14 (24.6%) | 14 (24.6%) | 29 (50.9%) | 30 (28.9%) | 16 (15.4%) | 58 (55.8%) | 0.46 | 28.5 (11.0) | 18.5 (12.3) | <0.001 |
| JOAG | 96 (15 to 156) | 4 (30.8%) | 2 (15.4%) | 7 (53.9%) | 3 (20.0%) | 1 (6.7%) | 11 (73.3%) | 0.37 | 25.6 (14.3) | 15.00 (6.8) | <0.001 |
| SCG-C | 47.5 (25 to 114) | 12 (28.6%) | 17 (40.5%) | 13 (31.0%) | 17 (34.0%) | 18 (36.0%) | 15 (30.0%) | 0.25 | 27.2 (9.3) | 17.2 (6.6) | <0.001 |
| SCG-S | 57 (27 to 111) | 6 (30.0%) | 10 (50.0%) | 4 (20.0%) | 13 (46.4%) | 7 (25.0%) | 8 (28.6%) | 0.17 | 26.3 (9.5) | 15.9 (7.6) | <0.001 |
| SCG-O | 75 (40 to 138) | 17 (37.8%) | 7 (15.6%) | 21 (46.7%) | 22 (21.2%) | 16 (15.4%) | 66 (63.5%) | 0.07 | 29.9 (12.1) | 21.6 (10.8) | <0.001 |
| SCG-A | 38 (16 to 81) | 50 (57.5%) | 8 (9.2%) | 29 (33.3%) | 55 (53.4%) | 6 (5.8%) | 42 (40.8%) | 0.40 | 28.6 (11.1) | 19.3 (11.3) | <0.001 |
* Calculated from the paired data of eyes with available initial visual acuity and latest visual acuity- all glaucoma 253 pairs, PCG 53 pairs, JOAG 13 pairs, SCG-C 42 pairs, SCG-S 17, SCG-O 41 pairs, and SCG-A 87 pairs.
† Calculated from the paired data of eyes with available initial intraocular pressure and latest intraocular pressure- all glaucoma 634 pairs, PCG 129 pairs, JOAG 14 pairs, SCG-C 53 pairs, SCG-S 41, SCG-O 139 pairs, and SCG-A 110 pairs.
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions.
Ordinal logistic regression demonstrating factors associated with last visual acuity.
| Odds ratio | 95% CI | P value | |
|---|---|---|---|
| Initial visual acuity | |||
| • Favorable | reference | ||
| • Moderately favorable | 10.85 | 4.49 to 26.27 |
|
| • Unfavorable | 70.15 | 27.37 to 179.83 |
|
| Initial IOP | 1.03 | 1 to 1.07 | 0.086 |
| Last IOP | 1.08 | 1.03 to 1.13 |
|
| Age at presentation | 0.99 | 0.99 to 1 | 0.088 |
| Glaucoma diagnosis | |||
| • PCG | 3.26 | 1.08 to 9.78 |
|
| • JOAG | 26.99 | 2.23 to 326.5 |
|
| • SCG-C | reference | ||
| • SCG-S | 1.13 | 0.32 to 3.97 | 0.847 |
| • SCG-O | 5.60 | 1.78 to 17.59 |
|
| • SCG-A | 1.38 | 0.53 to 3.57 | 0.510 |
Parallel line analysis of ordinal logistic regression
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions.
Visual acuity of eyes with available initial visual acuity and latest visual acuity.
| Last visual acuity N (%) | ||||
|---|---|---|---|---|
| Favorable | Mod. favorable | Unfavorable | ||
| PCG | Favorable | 9 |
| |
| Mod. favorable |
| 4 |
| |
| Unfavorable |
| 23 | ||
| JOAG | Favorable | 3 |
| |
| Mod. favorable | 1 |
| ||
| Unfavorable | 7 | |||
| SCG-C | Favorable | 11 |
| |
| Mod. favorable |
| 11 |
| |
| Unfavorable |
|
| 8 | |
| SCG-S | Favorable | 6 | ||
| Mod. favorable |
| 4 |
| |
| Unfavorable |
| 3 | ||
| SCG-O | Favorable | 5 |
|
|
| Mod. favorable |
|
| ||
| Unfavorable |
|
| 14 | |
| SCG-A | Favorable | 47 |
|
|
| Mod. favorable |
| 3 |
| |
| Unfavorable |
| 28 | ||
Bold indicates eyes with worsening of the visual acuity group. Italic indicates eyes with improvement of the visual acuity group.
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions.
Distribution of childhood glaucoma according to the Childhood Glaucoma Research Network classification.
| Study | Number of
| Population | PCG | JOAG | SCG-C | SCG-S | SCG-O | SCG-A |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Current study | 338 | 2 Tertiary paediatric glaucoma clinics, Thailand | 88 (26%) | 8 (2.4%) | 33 (9.8%) | 32 (9.5%) | 97 (28.7%) | 80 (23.6%) |
| Senthil
| 275 | Tertiary eye care, India | 107(38.9%) | 38 (13.8%) | 22 (8%) | 16 (5.8%) | 48 (17.5%) | 44 (16%) |
| Mokbel
| 207 | Chief referral center, Egypt | 114 (55%) | 2 (1%) | 15 (7.2%) | 4 (2%) | 11 (5.3%) | 61 (29.5%) |
| Hoguet
| 122 | Tertiary childhood glaucoma clinic, USA | 39 (32%) | 9 (7.4%) | 22 (18%) | 14 (11.5%) | 10 (8.2%) | 28 (22.9%) |
| Fung
| 152
| Dallas Glaucoma Registry, USA | 46 (30.3%) | 10 (6.6%) | 30 (19.7%) | 18 (11.8%) | 16 (10.5%) | 32 (21.1%) |
| Qiao
| 948 | Hospitalized paediatric patients, Beijing, China | 486 (51.3%) | 63 (6.6%) | 125 (13.2%) | 40 (4.2%) | 61 (6.4%) | 173 (18.3%) |
| Taylor
| 296
| Hospital for sick children, Toronto, Canada | 117 (39.5%) | 7 (2.4%) | 61 (20.6%) | 32 (10.8%) | 38 (12.8%) | 41 (13.9%) |
| Barsoum-Homsy
| 63 | Paediatric glaucoma clinic, Montreal, Canada | 14 (22.2%) | 0 | 7 (11.1%) | 9 (14.2%) | 24 (38%) | 9 (14.2%) |
|
| ||||||||
| Aponte
| 30 | Olmstead county residents, Minnesota, USA | 1 (3.3%) | 4 (13.3%) | 6 (20%) | 4 (13.4%) | 2 (6.7%) | 13 (43.3%) |
| Papadppoulos
| 91
| British Ophthalmic Surveillance Unit, Great
| 45 (49.4%) | 2 (2.2%) | 16 (17.6%) | 12 (13.2%) | 6 (6.6%) | 10 (11%) |
* We excluded patients who were glaucoma suspect or had an unknown diagnosis.
† The diagnosis was reclassified from the original articles to follow the CGRN classification.
PCG, primary congenital glaucoma; JOAG, juvenile open angle glaucoma; SCG-C, secondary glaucoma following cataract surgery; SCG-S, secondary glaucoma associated with non-acquired systemic condition; SCG-O, secondary glaucoma associated with ocular anomalies; SCG-A, secondary glaucoma associated with acquired conditions